Shukra Pharmaceuticals Ltd (SHUKRAPHAR) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 505931, "name": "Shukra Pharma.", "stock_name": "Shukra Pharma.", "full_name": "Shukra Pharmaceuticals Ltd", "name_url": "stocks-analysis/shukra-pharma", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "55.76", "chg": -1.03, "chgp": "-1.81%", "dir": -1, "prev_price": "56.79", "mcapval": "", "mcap": "Micro Cap", "scripcode": 524632, "symbol": "SHUKRAPHAR", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE551C01044", "curr_date": "Sep 24, 03:30 PM", "curr_time": "17:48 PM", "last_traded_at": "Sep 24, 03:30 PM IST", "bse_nse_vol": "2.82 lacs", "exc_status": "Active", "traded_date": "Sep 24, 2026", "traded_date_str": "2026 09 24", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/shukra-pharma-505931-1&utm_source=Spage_Header_Score", "mojoone": { "text": "Part of MojoOne Strategy", "type": "MN", "url": "https://www.marketsmojo.com/mojopro/strategy/2", "ismore": 0, "all_data": [], "is_blur": 1, "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/shukra-pharma-505931-1&utm_source=Spage_Score_PartofStrategies" } }, "news": { "results": [ { "title": "Shukra Pharmaceuticals Upgraded to Buy on Strong Financial and Technical Momentum", "link": "https://www.marketsmojo.com/news/stock-recommendation/shukra-pharmaceuticals-upgraded-to-buy-on-strong-financial-and-technical-momentum-4201863", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ShukraPharmaceu_mojoScore_4201863.png", "date": "2026-09-23 08:11:46", "description": "Shukra Pharmaceuticals Ltd has been upgraded from a Hold to a Buy rating following a marked improvement in its technical indicators, robust financial trends, and sustained quality metrics. The micro-cap pharmaceutical company’s recent performance has outpaced market benchmarks, prompting a reassessment of its investment appeal." }, { "title": "Shukra Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-ltd-technical-momentum-shifts-signal-bullish-outlook-4201681", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ShukraPharmaceu_technicaldot_4201681.png", "date": "2026-09-23 08:01:54", "description": "Shukra Pharmaceuticals Ltd has demonstrated a significant shift in price momentum, supported by a series of bullish technical indicators and an upgrade in its Mojo Grade from Hold to Buy. The micro-cap pharmaceutical company’s shares surged 6.32% on 23 Sep 2026, closing at ₹58.73, signalling renewed investor confidence amid a broader positive technical trend." }, { "title": "Shukra Pharmaceuticals Ltd Sees Mixed Technical Signals Amid Price Momentum Shift", "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-ltd-sees-mixed-technical-signals-amid-price-momentum-shift-4199031", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ShukraPharmaceu_technicaldot_4199031.png", "date": "2026-09-21 08:01:33", "description": "Shukra Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish trend as of mid-September 2026. Despite a recent downgrade from a Buy to a Hold rating by MarketsMOJO, the stock’s price action and technical indicators reveal a complex interplay of bullish and bearish signals, reflecting cautious optimism in the micro-cap pharmaceutical sector." }, { "title": "Shukra Pharmaceuticals Gains 3.74%: 3 Key Factors Driving the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-gains-374-3-key-factors-driving-the-week-4198472", "imagepath": "", "date": "2026-09-19 17:02:45", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>15 Sep:</strong> Mojo Grade downgraded to Hold amid mixed technicals and expensive valuation</p>\n <p><strong>16 Sep:</strong> Technical momentum shifts to mildly bullish with mixed indicator signals</p>\n <p><strong>18 Sep:</strong> Technical trend upgraded to bullish despite slight price dip</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.53.94</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.55.96</div><div class=\"stat-change positive\">+3.74%</..." }, { "title": "Shukra Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4196702", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ShukraPharmaceu_technicaldot_4196702.png", "date": "2026-09-18 08:02:11", "description": "Shukra Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite a slight dip in the stock price on 18 Sep 2026, the evolving technical indicators suggest a potential strengthening in price momentum, warranting close attention from investors and market analysts alike." }, { "title": "Shukra Pharmaceuticals Downgraded to Hold Amid Mixed Technicals and Expensive Valuation", "link": "https://www.marketsmojo.com/news/stock-recommendation/shukra-pharmaceuticals-downgraded-to-hold-amid-mixed-technicals-and-expensive-valuation-4194503", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ShukraPharmaceu_mojoScore_4194503.png", "date": "2026-09-16 08:39:50", "description": "Shukra Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 15 Sep 2026. This adjustment reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technicals. Despite robust financial performance and impressive long-term returns, the stock’s technical indicators and premium valuation have prompted a more cautious stance." }, { "title": "Shukra Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4194090", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ShukraPharmaceu_technicaldot_4194090.png", "date": "2026-09-16 08:04:20", "description": "Shukra Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, transitioning from a bullish to a mildly bullish stance. Despite a 2.5% gain on 16 Sep 2026, the stock’s technical indicators present a complex picture, with some weekly and monthly signals diverging. This article analyses the recent price action, key technical indicators, and the implications for investors amid the broader market context." }, { "title": "Shukra Pharmaceuticals Gains 3.81%: 3 Key Factors Driving the Move", "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-gains-381-3-key-factors-driving-the-move-4191585", "imagepath": "", "date": "2026-09-12 16:02:46", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>7 Sep:</strong> Stock opens at Rs.53.07, rising 2.14% despite Sensex decline</p>\n <p><strong>10 Sep:</strong> Formation of Golden Cross signals potential bullish breakout</p>\n <p><strong>10 Sep:</strong> Mojo Grade upgraded from Hold to Buy on strong fundamentals</p>\n <p><strong>11 Sep:</strong> Technical momentum shifts to bullish despite minor price dip</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.51.96</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</..." }, { "title": "Shukra Pharmaceuticals Upgraded to Buy on Strong Financials and Bullish Technicals", "link": "https://www.marketsmojo.com/news/stock-recommendation/shukra-pharmaceuticals-upgraded-to-buy-on-strong-financials-and-bullish-technicals-4189909", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/ShukraPharmaceu_mojoScore_4189909.png", "date": "2026-09-11 08:10:01", "description": "Shukra Pharmaceuticals Ltd has been upgraded from a Hold to a Buy rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. The upgrade reflects the company’s robust quarterly results, impressive long-term growth, and a shift to a bullish technical outlook, positioning it favourably within the Pharmaceuticals & Biotechnology sector." } ], "total": 677, "sid": "505931", "stock_news_url": "https://www.marketsmojo.com/news/shukra-pharmaceuticals-505931" }, "announcements": "", "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Shukra Pharmaceuticals Ltd has declared <strong>1%</strong> dividend, ex-date: 21 Sep 26", "dt": "2026-09-21", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Shukra Pharmaceuticals Ltd has announced <strong>1:10</strong> stock split, ex-date: 21 Mar 25", "dt": "2025-03-21", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Shukra Pharmaceuticals Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 19 Apr 24", "dt": "2024-04-19", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "", "data": [ { "txt": "Shukra Pharmaceuticals Ltd has announced <strong>6:1</strong> rights issue, ex-date: 02 Feb 23", "dt": "2023-02-02", "middle_text": "Rights Issue" } ] } ] }

Key Events This Week

15 Sep: Mojo Grade downgraded to Hold amid mixed technicals and expensive valuation

16 Sep: Technical momentum shifts to mildly bullish with mixed indicator signals

18 Sep: Technical trend upgraded to bullish despite slight price dip

+3.74%Read full news article

Shukra Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-09-18 08:02:11

Shukra Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite a slight dip in the stock price on 18 Sep 2026, the evolving technical indicators suggest a potential strengthening in price momentum, warranting close attention from investors and market analysts alike.

Read full news article

Shukra Pharmaceuticals Downgraded to Hold Amid Mixed Technicals and Expensive Valuation

2026-09-16 08:39:50

Shukra Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 15 Sep 2026. This adjustment reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technicals. Despite robust financial performance and impressive long-term returns, the stock’s technical indicators and premium valuation have prompted a more cautious stance.

Read full news article

Shukra Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-09-16 08:04:20

Shukra Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, transitioning from a bullish to a mildly bullish stance. Despite a 2.5% gain on 16 Sep 2026, the stock’s technical indicators present a complex picture, with some weekly and monthly signals diverging. This article analyses the recent price action, key technical indicators, and the implications for investors amid the broader market context.

Read full news article

Shukra Pharmaceuticals Gains 3.81%: 3 Key Factors Driving the Move

2026-09-12 16:02:46

Key Events This Week

7 Sep: Stock opens at Rs.53.07, rising 2.14% despite Sensex decline

10 Sep: Formation of Golden Cross signals potential bullish breakout

10 Sep: Mojo Grade upgraded from Hold to Buy on strong fundamentals

11 Sep: Technical momentum shifts to bullish despite minor price dip

Week Open

Rs.51.96

Week CloseRead full news article

Shukra Pharmaceuticals Upgraded to Buy on Strong Financials and Bullish Technicals

2026-09-11 08:10:01

Shukra Pharmaceuticals Ltd has been upgraded from a Hold to a Buy rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. The upgrade reflects the company’s robust quarterly results, impressive long-term growth, and a shift to a bullish technical outlook, positioning it favourably within the Pharmaceuticals & Biotechnology sector.

Read full news article

View All News